Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Infants Uniquely Express High Levels of RBM3 and Other Cold-Adaptive Neuroprotectant Proteins in the Human Brain.

Jackson TC, Kotermanski SE, Kochanek PM.

Dev Neurosci. 2018;40(4):325-336. doi: 10.1159/000493637. Epub 2018 Nov 6.

2.

Oxidative stress induces release of 2'-AMP from microglia.

Jackson TC, Kotermanski SE, Kochanek PM, Jackson EK.

Brain Res. 2019 Mar 1;1706:101-109. doi: 10.1016/j.brainres.2018.11.002. Epub 2018 Nov 3.

PMID:
30395838
3.

Acute Physiology and Neurologic Outcomes after Brain Injury in SCOP/PHLPP1 KO Mice.

Jackson TC, Dixon CE, Janesko-Feldman K, Vagni V, Kotermanski SE, Jackson EK, Kochanek PM.

Sci Rep. 2018 May 8;8(1):7158. doi: 10.1038/s41598-018-25371-2.

4.

BrainPhys® increases neurofilament levels in CNS cultures, and facilitates investigation of axonal damage after a mechanical stretch-injury in vitro.

Jackson TC, Kotermanski SE, Jackson EK, Kochanek PM.

Exp Neurol. 2018 Feb;300:232-246. doi: 10.1016/j.expneurol.2017.11.013. Epub 2017 Dec 1.

5.

Whole-transcriptome microarray analysis reveals regulation of Rab4 by RBM5 in neurons.

Jackson TC, Kotermanski SE, Kochanek PM.

Neuroscience. 2017 Oct 11;361:93-107. doi: 10.1016/j.neuroscience.2017.08.014. Epub 2017 Aug 15.

6.

Adenosine production by brain cells.

Jackson EK, Kotermanski SE, Menshikova EV, Dubey RK, Jackson TC, Kochanek PM.

J Neurochem. 2017 Jun;141(5):676-693. doi: 10.1111/jnc.14018. Epub 2017 Apr 6.

7.

Cold stress protein RBM3 responds to temperature change in an ultra-sensitive manner in young neurons.

Jackson TC, Manole MD, Kotermanski SE, Jackson EK, Clark RS, Kochanek PM.

Neuroscience. 2015 Oct 1;305:268-78. doi: 10.1016/j.neuroscience.2015.08.012. Epub 2015 Aug 8.

8.

Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats.

Kotermanski SE, Johnson JW, Thiels E.

Pharmacol Biochem Behav. 2013 Aug;109:67-76. doi: 10.1016/j.pbb.2013.05.005. Epub 2013 May 8.

9.

Memantine binding to a superficial site on NMDA receptors contributes to partial trapping.

Kotermanski SE, Wood JT, Johnson JW.

J Physiol. 2009 Oct 1;587(Pt 19):4589-604. doi: 10.1113/jphysiol.2009.176297. Epub 2009 Aug 17.

10.

Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.

Kotermanski SE, Johnson JW.

J Neurosci. 2009 Mar 4;29(9):2774-9. doi: 10.1523/JNEUROSCI.3703-08.2009.

11.

Mechanism of action of memantine.

Johnson JW, Kotermanski SE.

Curr Opin Pharmacol. 2006 Feb;6(1):61-7. Epub 2005 Dec 20. Review.

PMID:
16368266

Supplemental Content

Loading ...
Support Center